Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DANAPAROID for Pulmonary embolism: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 15 adverse event reports in the FDA FAERS database where DANAPAROID was used for Pulmonary embolism.

Most Reported Side Effects for DANAPAROID

Side Effect Reports % Deaths Hosp.
Heparin-induced thrombocytopenia 27 15.9% 8 19
Acute kidney injury 14 8.2% 11 3
Shock haemorrhagic 14 8.2% 11 2
Haematoma 12 7.1% 9 4
Thrombocytopenia 12 7.1% 3 5
Off label use 11 6.5% 2 8
Deep vein thrombosis 10 5.9% 2 7
International normalised ratio increased 10 5.9% 7 3
Anaemia 9 5.3% 0 8
Haemorrhage 9 5.3% 5 0
Maternal exposure during pregnancy 9 5.3% 0 0
Rectal haemorrhage 9 5.3% 1 8
Cerebral haemorrhage 8 4.7% 8 2
Stevens-johnson syndrome 8 4.7% 8 0
Condition aggravated 7 4.1% 1 6

Other Indications for DANAPAROID

Product used for unknown indication (50) Heparin-induced thrombocytopenia (34) Thrombosis prophylaxis (22) Anticoagulant therapy (18) Thrombocytopenia (5)

Other Drugs Used for Pulmonary embolism

RIVAROXABAN (11,707) APIXABAN (5,234) WARFARIN (1,552) ENOXAPARIN (1,155) HEPARIN (786) ALTEPLASE (617) DABIGATRAN ETEXILATE (527) DALTEPARIN (431) EDOXABAN (307) XARELTO (284)

Related Pages

DANAPAROID Full Profile All Pulmonary embolism Drugs DANAPAROID Demographics DANAPAROID Timeline